Breaking Finance News

Jefferies & Co announced West Pharmaceutical (NYSE:WST), boosting its stock price target to $90.00 today

Just yesterday West Pharmaceutical (NYSE:WST) traded 0.77% higher at $98.73. West Pharmaceutical’s 50-day moving average is $91.92 and its 200-day moving average is $91.09. The last stock price is up 3.93% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has increased 0.03% over the same time period. 269,610 shares of WST traded hands, down from an average trading volume of 383,957

In a report released on Thursday June 08, 2017 Jefferies & Co increased the stock price target of West Pharmaceutical (NYSE:WST) to $90.00 reporting a possible downside of -0.09%.

Recent Performance Chart

West Pharmaceutical (NYSE:WST)

West Pharmaceutical has 52 week low of $70.17 and a 52 week high of $99.91 with a PE ratio of 40.63 and has a market capitalization of $0.

In addition to Jefferies & Co reporting its target price, a total of 4 firms have reported on the stock. The consensus target price is $66.00 with 2 firms rating the stock a strong buy, 1 firm rating the stock a buy, 1 firm rating the stock a hold, 0 firms rating the stock a underperform, and finally 0 firms rating the stock a sell.

About West Pharmaceutical (NYSE:WST)

West Pharmaceutical Services, Inc. is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company's products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services. The Company's segments include Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment develops commercial and operational strategies across its global network, with specific emphasis on product offerings to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as an integrated business focused on the design, manufacture and automated assembly of various devices, primarily for pharmaceutical, diagnostic and medical device customers.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.